Beam Therapeutics BEAM Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Beam Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Beam Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Beam Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Beam Therapeutics's operating lease liabilities (current)?
- Beam Therapeutics (BEAM) reported operating lease liabilities (current) of $14.78M in Q1 2026.
- How has Beam Therapeutics's operating lease liabilities (current) changed year-over-year?
- Beam Therapeutics's operating lease liabilities (current) increased by 11.9% year-over-year, from $13.21M to $14.78M.
- What is the long-term trend for Beam Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Beam Therapeutics's operating lease liabilities (current) has grown at a 27.8% compound annual growth rate (CAGR), from $4.22M to $14.36M.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.